Open an account

Comera Life Sciences Holdings

CMRA · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket closed ·
No price history for this range.

About CMRA

Comera Life Sciences Holdings, Inc. engages in developing medicines. The company is headquartered in Woburn, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2020-12-15. The firm applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The firm is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. The company also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.

Employees
12
Headquarters
Woburn, Massachusetts
Listed
Dec 15, 2020
Sector
Health Care
Industry
Biotechnology
Website
comeralifesciences.com

CMRA key statistics

Market cap
3.07K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.57K
Volume
11
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.00

Comera Life Sciences Holdings (CMRA) at a glance

Comera Life Sciences Holdings (CMRA) last traded at $0.0001, with a market cap of 3.07K and a price-to-earnings ratio of 0.00.

Volume so far is 11 shares, below the average of 1.57K shares a day.

Over the past year Comera Life Sciences Holdings has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.